Remedium Lifecare
Remedium Lifecare (SUPHA) share price was ₹0.25 at the 28 Oct 2026 close; market capitalisation ₹22.08 Cr; P/E (TTM) 2.50; sector Commercial Services. The share price fell 83.8% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Sep 2025 quarter, revenue was ₹111.06 Cr and net profit was ₹8.62 Cr. Promoters held 1.13% of Remedium Lifecare in Dec 2025, unchanged from Sep 2025. Its Tapetide Score is 40/100 (Weak) as of 28 Oct 2026.
Key Fundamentals
MicrocapCommercial ServicesServicesPrice-based figures as of 28 Oct 2026, 15:30 IST · TTM
Peer Comparison
Services › Commercial Services › Trading & Distributors
| ₹350.25 | 16.10 | 27,382 Cr | 2.69 | 1.68% | 12.32% | 19.00% | 1,28,312 Cr | 1,504 Cr | |
| ₹51.55 | 17.30 | 7,733 Cr | 3.65 | 0.00% | 18.27% | 29.75% | 908 Cr | 447 Cr | |
| ₹567.85 | 17.06 | 3,998 Cr | 4.42 | 2.82% | 24.16% | 31.29% | 478 Cr | 234 Cr | |
| ₹1,171.00 | 23.87 | 1,758 Cr | 4.39 | 0.05% | 18.15% | 26.34% | 2,794 Cr | 74 Cr | |
| — | — | 1,104 Cr | 12.25 | 0.00% | -0.05% | 0.02% | 40 Cr | -0 Cr | |
| — | — | 810 Cr | 59.90 | 0.00% | 53.72% | 74.36% | 12 Cr | -2 Cr | |
Remedium Lifecare (this company) | — | 2.50 | 22 Cr | 0.24 | 0.00% | 4.85% | 22.04% | 496 Cr | 11 Cr |
| Median 7 companies | ₹459.05 | 17.06 | 1,758 Cr | 4.39 | 0.00% | 18.15% | 26.34% | 496 Cr | 74 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 85/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Stock is trading at 0.21 times its book value
Weaknesses
4- Company has low interest coverage ratio.
- Promoter holding is low: 1.13%
- Earnings include an other income of Rs.10.8 Cr.
- Company has high debtors of 695 days.
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
Operating margin 6.65% · Sep 2025
Quarterly Results
| Particulars | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|
| Sales | 264 | 113 | 111 |
| Expenses | 265 | 112 | 104 |
| Operating Profit | -0.46 | 1.87 | 7.38 |
| OPM % | -0.17% | 1.65% | 6.65% |
| Other Income | 0.66 | 3.48 | 3.25 |
| Interest | 1.59 | -0.36 | 0.19 |
| Depreciation | 0.01 | 0 | 0 |
| PBT | -1.4 | 5.71 | 10.44 |
| Tax % | 45.71% | 18.56% | 17.34% |
| Net Profit | -2.05 | 4.65 | 8.62 |
| EPS (₹) | -0.02 | 0.05 | 0.1 |
Profit & Loss
| Particulars | Mar 2025 |
|---|---|
| Sales | 405 |
| Expenses | 404 |
| Operating Profit | 1 |
| OPM % | 0.3% |
| Other Income | 11 |
| Interest | 8 |
| Depreciation | 0 |
| PBT | 4 |
| Tax % | 51% |
| Net Profit | 2 |
| EPS (₹) | 0.02 |
| Div. Payout % | 0% |
Balance Sheet
| Particulars | Mar 2025 | Sep 2025 |
|---|---|---|
| Equity Capital | 40 | 88 |
| Reserves | 4 | 17 |
| Borrowings | 1,141 | 1,088 |
| Other Liabilities | 535 | 430 |
| Total Liabilities | 1,720 | 1,623 |
| Fixed Assets | 0 | 6 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 1,720 | 1,617 |
| Total Assets | 1,720 | 1,623 |
Cash Flow
| Particulars | Mar 2025 |
|---|---|
| Operating | -1,135 |
| Investing | 0 |
| Financing | 1,136 |
| Net Cash Flow | 1 |
| Free Cash Flow | -1,135 |
| CFO/OP | -90,064 |
Ratios
| Particulars | Mar 2025 |
|---|---|
| Debtor Days | 695 |
| Inventory Days | 247 |
| Days Payable | 459 |
| Cash Conversion Cycle | 483 |
| Working Capital Days | 38 |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Remedium Lifecare insights
58 extracted metrics + investor summaries across FY11–FY26.
Documents
Frequently Asked Questions about Remedium Lifecare
What does Remedium Lifecare Ltd do?
Where is Remedium Lifecare Ltd (SUPHA) listed?
Which sector does Remedium Lifecare Ltd belong to?
What is the market capitalisation of Remedium Lifecare Ltd?
What is the PE ratio of Remedium Lifecare Ltd?
What is the 52-week high and low of Remedium Lifecare Ltd?
What is the Return on Equity (ROE) of Remedium Lifecare Ltd?
Company Information
Supha Pharmachem Ltd, formerly Remedium Lifecare, is a pharmaceutical supply-chain trader of APIs, advanced intermediates, KSMs/CRMs and other pharma chemicals for domestic and export markets. It operates through the Indian parent and Singapore subsidiary Remlife Global Pte Ltd and entered CIRP on March 17, 2026. [1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539561.md for Remedium Lifecare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.